Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-078417
Filing Date
2014-12-30
Accepted
2014-12-30 17:28:55
Documents
2
Period of Report
2014-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14840
2 EX-24 DOCUMENT attachment1.htm EX-24 3691
  Complete submission text file 0001209191-14-078417.txt   20123
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O ARCA BIOPHARMA, INC. 11080 CIRCLEPOINT RD, STE 140 WESTMINSTER CO 80020
Business Address
Keuer Thomas A (Reporting) CIK: 0001290482 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-22873 | Film No.: 141316764